ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,932Medicare Part D Prescriptions Filled, Including Refills

Rank: 80 out of 939

$724K Total Retail Price of All Prescriptions

Rank: 119 out of 939

886 Patients Receiving at Least One Drug in Part D
26%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 886 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

48% of this provider’s 886 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 5,642 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 1,546 295 S3 1 1
SIMVASTATIN 657 327 2 2
LISINOPRIL 637 256 3 3
AMLODIPINE BESYLATE 564 257 4 6
FUROSEMIDE 421 178 5 7
METOPROLOL TARTRATE 386 171 6 10
CLONIDINE HCL 386 112 6 39
HYDROCHLOROTHIAZIDE 367 130 8 12
OMEPRAZOLE 355 103 9 5
METFORMIN HCL 335 116 10 8
GABAPENTIN 306 84 11 11
ZOLPIDEM TARTRATE 272 47 12 20
OXYCODONE HCL-ACETAMINOPHEN 259 58 S2 13 107
POTASSIUM CHLORIDE 222 73 14 9
ENDOCET 209 19 S2 15 148
PROMETHAZINE HCL 209 18 R 15 68
LEVOTHYROXINE SODIUM 207 109 17 4
NEXIUM 196 23 18 18
MELOXICAM 178 86 19 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 171 31 20 23
CYCLOBENZAPRINE HCL 164 11 R 21 36
PROAIR HFA 159 45 22 41
CARISOPRODOL 157 0 R 23 51
AZITHROMYCIN 153 35 24 32
TRAMADOL HCL 149 38 25 16
ATENOLOL 148 74 26 19
GLIMEPIRIDE 145 58 27 37
HYDRALAZINE HCL 118 61 28 130
TRIAMTERENE-HCTZ 116 45 29 33
FLUCONAZOLE 112 11 30 140
NAPROXEN 110 37 31 72
TAMSULOSIN HCL 108 46 32 27
CARVEDILOL 107 51 33 25
CLOPIDOGREL 105 48 34 28
ATORVASTATIN CALCIUM 101 52 35 22
PRAVASTATIN SODIUM 96 46 36 13
AMITRIPTYLINE HCL 94 58 R 37 38
NIFEDIPINE ER 92 45 38 105
INSULIN SYRINGE 88 30 39 97
DIOVAN HCT 87 28 40 74
CRESTOR 86 27 41 34
LYRICA 84 0 42 63
METOPROLOL SUCCINATE 83 45 43 21
IBUPROFEN 81 26 44 112
METHYLPREDNISOLONE 80 26 45 118
RANITIDINE HCL 80 42 45 35
AMLODIPINE BESYLATE-BENAZEPRIL 79 33 47 58
PHENYTOIN SODIUM EXTENDED 78 0 48 99
TRAZODONE HCL 77 0 49 26
DIOVAN 75 23 50 50
ZETIA 74 28 51 103
SERTRALINE HCL 74 27 51 24
GLIPIZIDE 74 29 51 52
DONEPEZIL HCL 72 70 54 30
CITALOPRAM HBR 71 0 55 15
JANUVIA 71 35 55 110
FAMOTIDINE 70 31 57 62
ESTRADIOL 70 0 R 57 79
PLAVIX 69 30 59 48
ISOSORBIDE MONONITRATE ER 69 12 59 53
SULFAMETHOXAZOLE-TRIMETHOPRIM 69 0 59 64
GLYBURIDE 66 33 R 62 89
KLOR-CON M20 66 32 62 90
PREDNISONE 65 30 64 42
CEPHALEXIN 65 16 64 77
VENTOLIN HFA 64 18 66 80
ALLOPURINOL 63 37 67 31
PREMARIN 61 17 R 68 111
WARFARIN SODIUM 61 23 68 17
VERAPAMIL ER 59 27 70 85
RISPERIDONE 59 11 70 82
FLUOXETINE HCL 58 18 72 47
GLIPIZIDE ER 58 29 72 88
TIZANIDINE HCL 55 19 74 81
RAMIPRIL 54 35 75 91
CIPROFLOXACIN HCL 53 20 76 54
DOXAZOSIN MESYLATE 51 35 77 108
PANTOPRAZOLE SODIUM 51 17 77 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.